141 completed, 53 recruiting, 47 unknown, 39 terminated. 332 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 332 | Completed 141, Recruiting 53, Unknown 47, Terminated 39, Not yet recruiting 25, Active not recruiting 16, Withdrawn 10, Enrolling by invitation 1 |
Follow Leukemia, Myeloid: new trials by email Literature Review of Leukemia, Myeloid trials Research Report on Leukemia, Myeloid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Feasibility and Efficiency Study for the Implementation of a New Screening Method for Patients With Acute Myeloid Leukemia, in Laboratory Practice Bone marrow or peripheral blood withdrawal for test comparison - Acute Myeloid Leukemia, Acute Myeloid Leukemia, Adult | Not applicable | Not yet recruiting | Gruppo Italiano Malattie EMatologiche dell'Adulto | 75 | 2027-01-01 | 2026-10-09 |
| Improving Delivery of Aging-Related Supportive Care for Older Adults With Acute Myeloid Leukemia Active Default - Acute Myeloid Leukemia (AML) | Not applicable | Not yet recruiting | University of Alabama at Birmingham | 40 | 2027-01-01 | 2026-10-13 |
| Prevention of Oral Mucositis in Adults in With Hematologic Malignancy Aloe Vera Mouthwash, Standard of Care - Acute Leukemia, Acute Myeloid Leukemia | Not applicable | Not yet recruiting | Wake Forest University Health Sciences | 206 | 2027-01-01 | 2026-10-22 |
| Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies Ossium HPC, Marrow, Standard of care living donor - Haplo Related, Standard of care living donor - Mismatched Unrelated - Hematologic Malignancy, Acute Leukemia | Not applicable | Not yet recruiting | Ossium Health, Inc. | 300 | 2026-12-01 | 2026-09-10 |
| Digital Patient-Reported Assessment in Older Adults With Acute Leukemia Digital Patient-Reported Assessment Pathway - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Not applicable | Not yet recruiting | Fundación para la Investigación Biosanitaria del Principado de Asturias | 20 | 2026-12-01 | 2026-10-07 |
| A Home-Based Exercise Intervention (CAREFit-BMT) in Improving Heart Function Among Patients With High Risk Acute Myeloid Leukemia Undergoing Stem Cell Transplant Aerobic Exercise, Resistance Training, Biospecimen Collection - Acute Myeloid Leukemia | Not applicable | Recruiting | University of Washington | 30 | 2026-12-01 | 2026-10-29 |
| my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults my.naviGATE Digital Tool - Sarcoma, Osteosarcoma | Not applicable | Not yet recruiting | Dana-Farber Cancer Institute | 143 | 2026-11-20 | 2026-10-29 |
| Phenotypic and Functional Characterization of Bone Marrow Macrophages in Chronic Myelomonocytic Leukemia Bone marrow and blood samples, Bone marrow sample - Chronic Myelomonocytic Leukemia | Not applicable | Not yet recruiting | Centre Hospitalier Universitaire de Nice | 120 | 2026-11-01 | 2026-10-01 |
| MAC vs RIC for Transplantation in FLT3-ITD-Mutated AML Guided by UHS-NGS MRD ( FLT3 - MAC vs RIC ) RIC, MAC - ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Acute Myeloid Leukemia | Not applicable | Not yet recruiting | First Affiliated Hospital of Zhejiang University | 310 | 2026-11-01 | 2026-10-29 |
| Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms Biospecimen Collection, Bone Marrow Collection, Electronic Health Record Review - Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia | Not applicable | Recruiting | Fred Hutchinson Cancer Center | 50 | 2026-10-13 | 2026-10-19 |
| NAC for Hematopoietic Recovery in Low/Intermediate-Risk AML After CR: A Randomized Controlled Study N-acetyl-L-cysteine (NAC) - Acute Myeloid Leukemia, Adult | Not applicable | Not yet recruiting | Peking University People's Hospital | 180 | 2026-10-01 | 2026-10-09 |
| A Study of VABu Conditioning Regimen in Allo-HSCT for AML Patients Venetoclax, Azacitidine (AZA), Decitabine 20 mg/m²/day for 5 days - Leukemia, Myeloid, Acute(AML), Hematopoietic Stem Cell Transplantation (HSCT) | Not applicable | Not yet recruiting | The First Affiliated Hospital of Soochow University | 42 | 2026-08-01 | 2026-08-19 |
| ENERGIA: Personalized Exercise Program for Fatigue in Patients With Myeloproliferative Neoplasms and Chronic Myeloid Leukemia Participants will take part in a 12-week exercise program that includes aerobic and resistance training, tailored to their individual fitness level and clinical condition. - Myeloproliferative Disease, Polycythemia Vera | Not applicable | Not yet recruiting | Carmen Fava | 25 | 2026-08-01 | 2026-04-09 |
| eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation eHealth Mindfulness-based Music Therapy (eMBMT), eHealth Mindfulness Meditation (eMM) - Stem Cell Transplantation, Myelodysplastic Syndromes | Not applicable | Recruiting | University of Miami | 165 | 2026-07-22 | 2026-08-13 |
| Efficacy and Safety of the CloB2M (Clofarabine Combined With Busulfan and Melphalan) Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients With Acute Myeloid Leukemia in First Complete Remission CloB2M (Clofarabine Combined With Busulfan and Melphalan) Conditioning Regimen - AML (Acute Myelogenous Leukemia), Allogeneic Hematopoietic Stem Cell Transplantation Recipient | Not applicable | Not yet recruiting | Institute of Hematology & Blood Diseases Hospital, China | 30 | 2026-07-20 | 2026-06-12 |
| TBF Conditioning Regimen for Haploidentical Stem Cell Transplantation in Elderly AML Patients in First Complete Remission Thiotepa, Busulfan (BU), Fludarabine - Acute Myeloid Leukemia | Not applicable | Not yet recruiting | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 93 | 2026-06-01 | 2026-05-04 |
| ABC Maintenance Therapy for AML Cohort 1 (MRD-Negative Patients): 61 subjects, Cohort 2 (MRD-Persistent Positive Patients): 43 subjects - Acute Myeloid Leukemia (AML) in Remission | Not applicable | Not yet recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 104 | 2026-06-01 | 2026-04-09 |
| Halt Aging in Survivors of Blood Cancers Behavioral Coaching Intervention, Virtual Exercise Platform - Hematological Malignancy, Leukemia | Not applicable | Recruiting | University of Nebraska | 180 | 2026-04-09 | 2026-07-01 |
| A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patients Allogeneic Hematopoietic Stem Cell Transplantation - Relapsed or Refractory Acute Myeloid Leukemia (AML), MDS (Myelodysplastic Syndrome) | Not applicable | Recruiting | The First Affiliated Hospital of Soochow University | 30 | 2026-04-01 | 2026-04-15 |
| Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic Leukemia TBF regimen - Chronic Myelomonocytic Leukemia (CMML) | Not applicable | Recruiting | Peking University People's Hospital | 31 | 2026-02-13 | 2026-09-15 |
Showing 20 of 332. Sign in to see all of them.
Leukemia, Myeloid, Acute (266) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (100) · Myelodysplastic Syndromes (79) · Leukemia (69) · Lymphoma, Non-Hodgkin (66) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (62) · Multiple Myeloma (62) · Hodgkin Disease (61) · Leukemia, Lymphocytic, Chronic, B-Cell (58) · Burkitt Lymphoma (46) · Congenital Abnormalities (46) · Leukemia, Myeloid, Chronic-Phase (45) · Myeloproliferative Disorders (45) · Lymphoma, Mantle-Cell (44) · Lymphoma, Large B-Cell, Diffuse (42)
Hemic and Lymphatic Diseases (332) · Neoplasms by Histologic Type (332) · Hematologic Diseases (328) · Neoplasms (309) · Leukemia (263) · Bone Marrow Diseases (158) · Pathological Conditions, Signs and Symptoms (143) · Pathologic Processes (134) · Disease Attributes (125) · Immune System Diseases (125) · Immunoproliferative Disorders (122) · Lymphatic Diseases (122) · Lymphoproliferative Disorders (118) · Chronic Disease (112)
Busulfan (21) · Cyclophosphamide (21) · Cytarabine (20) · fludarabine phosphate (18) · venetoclax (17) · Cyclosporine (15) · Antilymphocyte Serum (14) · Azacitidine (13) · Peripheral Blood Stem Cell Transplantation (13) · Filgrastim (11) · Mycophenolic Acid (11) · fludarabine (11) · Blood Specimen Collection (10) · Granulocyte Colony-Stimulating Factor (10) · Melphalan (10)
Fred Hutchinson Cancer Center (13) · Wake Forest University Health Sciences (10) · Masonic Cancer Center, University of Minnesota (9) · Institute of Hematology & Blood Diseases Hospital, China (8) · M.D. Anderson Cancer Center (8) · Massachusetts General Hospital (8) · Gruppo Italiano Malattie EMatologiche dell'Adulto (7) · Institut Paoli-Calmettes (7) · University of Rochester (7) · City of Hope Medical Center (6) · Peking University People's Hospital (6) · Roswell Park Cancer Institute (6) · The First Affiliated Hospital of Soochow University (6) · University of Washington (6) · University of California, San Francisco (5)
United States (159) · China (57) · France (41) · Italy (16) · Canada (8) · Belgium (5) · Denmark (5) · Germany (5) · South Korea (5) · Turkey (Türkiye) (5) · Australia (4) · Israel (4) · Russia (4) · Spain (4) · Switzerland (4)
Areej El-Jawahri, MD (5) · Jianxiang Wang, MD (3) · Kah Poh Loh (3) · Suzanne C. Danhauer, PhD (3) · Antonio Curti (2) · Charles A. Linker, MD (2) · Claudio Brunstein, MD (2) · Damiano Rondelli, MD (2) · Huihan Wang, Doctor (2) · Jorge Cortes, MD (2) · Naeem Chaudhri, MD (2) · Pamela Becker (2) · Paul Martin (2)
PMID 38429079, PMID 32499241, PMID 10626925, PMID 11591090, PMID 12590031, PMID 14520621, PMID 14669295, PMID 15466923, PMID 17891547, PMID 18363482, PMID 18515696, PMID 18698002, PMID 18997171, PMID 19008455, PMID 19690306, PMID 19918155, PMID 20085940, PMID 20712465, PMID 20965785, PMID 21385856, PMID 21393334, PMID 21477979, PMID 21664296, PMID 21715313, PMID 21719601, PMID 21751984, PMID 21788559, PMID 22504933, PMID 22609885, PMID 22874874, PMID 23065508, PMID 23199641, PMID 23358983, PMID 23524640, PMID 24559581, PMID 24748496, PMID 24821357, PMID 24996833, PMID 25234438, PMID 25656326, PMID 25800762, PMID 25800768, PMID 25852056, PMID 25891003, PMID 26450984, PMID 26549852, PMID 26551633, PMID 26637760, PMID 26888022, PMID 27602666
P30CA015704 (10), P30CA033572 (5), 2018 (2), 4UL1TR000427-10 (2), P01CA018029 (2), P30CA012197 (2), P30CA014520 (2), P30CA016056 (2), P30CA072720 (2), K07CA136966 (1), KL2TR002317 (1), P01CA111412 (1), P01HL036444 (1), P30CA006973 (1), P30CA016672 (1)